Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21700708rdf:typepubmed:Citationlld:pubmed
pubmed-article:21700708lifeskim:mentionsumls-concept:C0030274lld:lifeskim
pubmed-article:21700708lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:21700708lifeskim:mentionsumls-concept:C0017932lld:lifeskim
pubmed-article:21700708lifeskim:mentionsumls-concept:C0132555lld:lifeskim
pubmed-article:21700708lifeskim:mentionsumls-concept:C0600437lld:lifeskim
pubmed-article:21700708lifeskim:mentionsumls-concept:C0033414lld:lifeskim
pubmed-article:21700708lifeskim:mentionsumls-concept:C0381451lld:lifeskim
pubmed-article:21700708lifeskim:mentionsumls-concept:C0699900lld:lifeskim
pubmed-article:21700708lifeskim:mentionsumls-concept:C0243125lld:lifeskim
pubmed-article:21700708lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:21700708lifeskim:mentionsumls-concept:C0547047lld:lifeskim
pubmed-article:21700708lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:21700708pubmed:issue33lld:pubmed
pubmed-article:21700708pubmed:dateCreated2011-8-15lld:pubmed
pubmed-article:21700708pubmed:abstractTextInsulin receptor substrate-2 (IRS-2) plays a critical role in the survival and function of pancreatic ?-cells. Gene disruption of IRS-2 results in failure of the ?-cell compensatory mechanism and diabetes. Nonetheless, the regulation of IRS-2 protein expression in ?-cells remains largely unknown. Inducible nitric-oxide synthase (iNOS), a major mediator of inflammation, has been implicated in ?-cell damage in type 1 and type 2 diabetes. The effects of iNOS on IRS-2 expression have not yet been investigated in ?-cells. Here, we show that iNOS and NO donor decreased IRS-2 protein expression in INS-1/832 insulinoma cells and mouse islets, whereas IRS-2 mRNA levels were not altered. Interleukin-1? (IL-1?), alone or in combination with interferon-? (IFN-?), reduced IRS-2 protein expression in an iNOS-dependent manner without altering IRS-2 mRNA levels. Proteasome inhibitors, MG132 and lactacystin, blocked the NO donor-induced reduction in IRS-2 protein expression. Treatment with NO donor led to activation of glycogen synthase kinase-3? (GSK-3?) and c-Jun N-terminal kinase (JNK/SAPK) in ?-cells. Inhibition of GSK-3? by pharmacological inhibitors or siRNA-mediated knockdown significantly prevented NO donor-induced reduction in IRS-2 expression in ?-cells. In contrast, a JNK inhibitor, SP600125, did not effectively block reduced IRS-2 expression in NO donor-treated ?-cells. These data indicate that iNOS-derived NO reduces IRS-2 expression by promoting protein degradation, at least in part, through a GSK-3?-dependent mechanism. Our findings suggest that iNOS-mediated decreased IRS-2 expression may contribute to the progression and/or exacerbation of ?-cell failure in diabetes.lld:pubmed
pubmed-article:21700708pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:languageenglld:pubmed
pubmed-article:21700708pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:citationSubsetIMlld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21700708pubmed:statusMEDLINElld:pubmed
pubmed-article:21700708pubmed:monthAuglld:pubmed
pubmed-article:21700708pubmed:issn1083-351Xlld:pubmed
pubmed-article:21700708pubmed:authorpubmed-author:TamuraYoshiak...lld:pubmed
pubmed-article:21700708pubmed:authorpubmed-author:KitamuraTadah...lld:pubmed
pubmed-article:21700708pubmed:authorpubmed-author:KanekiMasaoMlld:pubmed
pubmed-article:21700708pubmed:authorpubmed-author:ShimizuNobuyu...lld:pubmed
pubmed-article:21700708pubmed:authorpubmed-author:TaniokaToshih...lld:pubmed
pubmed-article:21700708pubmed:authorpubmed-author:KUSMMlld:pubmed
pubmed-article:21700708pubmed:authorpubmed-author:FukayaMakikoMlld:pubmed
pubmed-article:21700708pubmed:authorpubmed-author:ShinozakiShoh...lld:pubmed
pubmed-article:21700708pubmed:authorpubmed-author:KimMinhyeMlld:pubmed
pubmed-article:21700708pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21700708pubmed:day19lld:pubmed
pubmed-article:21700708pubmed:volume286lld:pubmed
pubmed-article:21700708pubmed:ownerNLMlld:pubmed
pubmed-article:21700708pubmed:authorsCompleteYlld:pubmed
pubmed-article:21700708pubmed:pagination29388-96lld:pubmed
pubmed-article:21700708pubmed:dateRevised2011-11-2lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:meshHeadingpubmed-meshheading:21700708...lld:pubmed
pubmed-article:21700708pubmed:year2011lld:pubmed
pubmed-article:21700708pubmed:articleTitleInducible nitric-oxide synthase and nitric oxide donor decrease insulin receptor substrate-2 protein expression by promoting proteasome-dependent degradation in pancreatic beta-cells: involvement of glycogen synthase kinase-3beta.lld:pubmed
pubmed-article:21700708pubmed:affiliationDepartment of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA.lld:pubmed
pubmed-article:21700708pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21700708pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:21700708pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:2932entrezgene:pubmedpubmed-article:21700708lld:entrezgene
entrez-gene:4843entrezgene:pubmedpubmed-article:21700708lld:entrezgene
entrez-gene:8660entrezgene:pubmedpubmed-article:21700708lld:entrezgene
entrez-gene:16847entrezgene:pubmedpubmed-article:21700708lld:entrezgene
entrez-gene:18126entrezgene:pubmedpubmed-article:21700708lld:entrezgene
entrez-gene:56637entrezgene:pubmedpubmed-article:21700708lld:entrezgene
entrez-gene:384783entrezgene:pubmedpubmed-article:21700708lld:entrezgene
entrez-gene:24599entrezgene:pubmedpubmed-article:21700708lld:entrezgene
entrez-gene:29376entrezgene:pubmedpubmed-article:21700708lld:entrezgene
entrez-gene:84027entrezgene:pubmedpubmed-article:21700708lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21700708lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21700708lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21700708lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21700708lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21700708lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21700708lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21700708lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21700708lld:entrezgene
More...